Select a community
All Communities
Home > Community Treatment Reports > Methylprednisolone Treatment Report
What is Methylprednisolone?

Methylprednisolone is a synthetic corticosteroid drug used primarily as an anti-inflammatory or immunosuppressant agent for diseases of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin; also for graft-versus-host disease.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell
# of patients evaluated by
MS Multiple Sclerosis 253 45
Other 198 38
Stiffness/Spasticity 57 10
Pain 46 8
relapse 41 11
Fatigue 32 12

See all 340 patients currently taking Methylprednisolone

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
29 16%
Moderate
64 36%
Mild
45 26%
None
38 22%

Most commonly reported side effects

Taste changed
44 35%
Sleeplessness
40 32%
Weight gain
36 29%
Insomnia
30 24%
Metallic taste in mouth
30 24%
Increased appetite
29 23%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Methylprednisolone. See all 98 dosages

  1000 as needed 1000 mg as needed 1000mg as needed 1 g as needed 1g as needed 1g monthly 1hours as needed 1mg as needed 1other as needed 20mg as needed 2 1g as needed 24mg as needed 250mg as needed 2g as needed 2 mg as needed 32mg as needed 3g as needed 40mg as needed 4 80mg/mL as needed 4 mg all the time (24/7) 4mg as needed 500mg as needed 50mg as needed 5 4mg as needed 5mg as needed 6 2mg as needed 80 mg as needed 8 500mg as needed as needed daily g as needed mg as needed monthly 3 g yearly 6 g yearly 1 g monthly 1 mEq/L monthly 1 monthly 1 other monthly 2 hr monthly 1 g every other week 1 mg every other week 3 g monthly 40 mg yearly 4 mg monthly 1 g weekly 64 mg yearly 2 mg weekly 4 mg weekly 24 mg monthly 1 daily 1 g daily 1 g one time 1 hr one time 40 mg monthly 60 mg monthly 2 hr daily 2 mg daily 84 mg monthly 3 g daily 3 g one time 3 hr one time 100 mg monthly 4 g daily 4 mg daily 125 mg monthly 5 g one time 6 mg daily 7.5 daily 8 mg daily 10 g daily 12 mg daily 16 mg daily 500 mg monthly 20 mg daily 20 mg one time 24 mg daily 1000 mg monthly 1024 mg monthly 500 mg every other week 40 mg daily 1500 mg monthly 50 intl units one time 50 mg daily 1000 mg every other week 500 mg weekly 80 mg daily 84 mg daily 96 mg daily 100 mg daily 1000 mg weekly 250 mg daily 500 mg daily 1000 daily 1000 g daily 1000 mcg daily 1000 mg daily 2000 mg daily
  3 Number of Patients: 3 1 Number of Patients: 1 14 Number of Patients: 14 2 Number of Patients: 2 22 Number of Patients: 22 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 5 Number of Patients: 5 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 11 Number of Patients: 11 18 Number of Patients: 18 1 Number of Patients: 1 2 Number of Patients: 2 7 Number of Patients: 7 1 Number of Patients: 1 1 Number of Patients: 1 30 Number of Patients: 30 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 31 Number of Patients: 31 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 17 Number of Patients: 17 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 8 Number of Patients: 8 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 26 Number of Patients: 26 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Methylprednisolone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
484 82% Course of treatment ended: 82%
Doctor's advice
53 9% Doctor's advice: 9%
Did not seem to work
40 7% Did not seem to work: 7%
Side effects too severe
31 5% Side effects too severe: 5%
Other
26 4% Other: 4%
Not indicated
24 4% Not indicated: 4%
Personal research
3 1% Personal research: 1%
Change in health plan coverage
1 0% Change in health plan coverage: 0%

See all 578 patients who’ve stopped taking Methylprednisolone

Currently Taking Methylprednisolone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Methylprednisolone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
155 88%
Usually
12 7%
Sometimes
5 3%
Never
4 2%

Burden

Difficulty being on treatment

Very
13 7%
Somewhat
49 28%
A little
41 23%
Not at all
73 41%

Cost

Paid out of pocket

$200+
10 6%
$100-199
7 4%
$50-99
9 5%
$25-49
1 1%
< $25
68 39%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 09, 2010.